rs587776578
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_016169.4(SUFU):c.1022+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016169.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUFU | NM_016169.4 | c.1022+1G>A | splice_donor_variant, intron_variant | ENST00000369902.8 | NP_057253.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUFU | ENST00000369902.8 | c.1022+1G>A | splice_donor_variant, intron_variant | 1 | NM_016169.4 | ENSP00000358918.4 | ||||
SUFU | ENST00000423559.2 | c.1022+1G>A | splice_donor_variant, intron_variant | 1 | ENSP00000411597.2 | |||||
SUFU | ENST00000369899.6 | c.1022+1G>A | splice_donor_variant, intron_variant | 1 | ENSP00000358915.2 | |||||
SUFU | ENST00000471000.1 | n.*2G>A | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461420Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727006
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Basal cell nevus syndrome 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2009 | - - |
SUFU-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Feb 12, 2019 | The SUFU c.1022+1G>A variant is a splice donor variant that has been identified in a heterozygous state in a father and son who met criteria for nevoid basal cell carcinoma syndrome (NBCCS) and in a patient with desmoplastic medulloblastoma who did not have physical features of NBCCS at 23 months of age (Slade et al. 2007; Pastorino et al. 2009). This variant was also identified in a desmoplastic medulloblastoma sample from an individual who had a germline deletion encompassing the SUFU gene (Taylor et al. 2002). This variant was absent from 200 control alleles and is not found in the Genome Aggregation Database. RT-PCR demonstrated this splice donor variant results in a protein lacking exon 8 and produces a frameshift which leads to an early stop codon and truncation of the protein (Pastorino et al. 2009). Co-precipitation studies showed this variant was unable to bind GLI1 and GLI2 transcription factors and accumulated with these transcription factors in the nucleus, thereby preventing suppression of hedgehog signaling pathway target genes (Taylor et al. 2002). Based on the evidence, the c.1022+1G>A variant is classified as pathogenic for SUFU-related disorders. - |
Gorlin syndrome;C0025149:Medulloblastoma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 09, 2023 | This sequence change affects a donor splice site in intron 8 of the SUFU gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site results in skipping of exon 8 and introduces a premature termination codon (PMID: 12068298, 19533801). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 3571). This variant is also known as IVS8+1G>A. Disruption of this splice site has been observed in individual(s) with desmoplastic medulloblastoma and/or Gorlin syndrome (PMID: 19533801, 21188540). In at least one individual the variant was observed to be de novo. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 09, 2022 | Canonical splice site variant demonstrated to result in a null allele in a gene for which loss-of-function is a known mechanism of disease (Taylor et al., 2002, Pastorino et al., 2009); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 12068298, 19533801, 22508808, 22829011, 24217340, 15077159, 29725392, 29186568, 21188540) - |
Medulloblastoma Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2009 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 16, 2020 | The c.1022+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide after coding exon 8 of the SUFU gene. This alteration has been reported in an individual with sporadic desmoplastic medulloblastoma diagnosed at age 23 months (Slade I et al. Fam Cancer, 2011 Jun;10:337-42). In addition, this alteration was detected in a father and son with a clinical diagnosis of Gorlin syndrome, and was absent in both of the father's clinically unaffected parents. Parentage was not confirmed, and the alteration was assumed to be de novo (Pastorino L et al. Am J Med Genet A, 2009 Jul;149A:1539-43). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at